VC
Vivo Capital’s ALX Oncology ALXO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-4,034,522
| Closed | -$7.34M | – | 42 |
|
2024
Q3 | $7.34M | Sell |
4,034,522
-185,526
| -4% | -$338K | 0.61% | 27 |
|
2024
Q2 | $25.4M | Hold |
4,220,048
| – | – | 2.35% | 9 |
|
2024
Q1 | $47.1M | Hold |
4,220,048
| – | – | 3.7% | 7 |
|
2023
Q4 | $62.8M | Hold |
4,220,048
| – | – | 5.14% | 5 |
|
2023
Q3 | $20.3M | Hold |
4,220,048
| – | – | 2.22% | 14 |
|
2023
Q2 | $31.7M | Hold |
4,220,048
| – | – | 2.19% | 11 |
|
2023
Q1 | $19.1M | Hold |
4,220,048
| – | – | 1.32% | 16 |
|
2022
Q4 | $47.6M | Hold |
4,220,048
| – | – | 5.48% | 4 |
|
2022
Q3 | $40.4M | Hold |
4,220,048
| – | – | 4.46% | 5 |
|
2022
Q2 | $34.1M | Hold |
4,220,048
| – | – | 3.43% | 6 |
|
2022
Q1 | $71.3M | Hold |
4,220,048
| – | – | 4.91% | 6 |
|
2021
Q4 | $90.7M | Hold |
4,220,048
| – | – | 5.47% | 5 |
|
2021
Q3 | $312M | Hold |
4,220,048
| – | – | 14% | 1 |
|
2021
Q2 | $231M | Hold |
4,220,048
| – | – | 9.99% | 2 |
|
2021
Q1 | $311M | Hold |
4,220,048
| – | – | 10.94% | 2 |
|
2020
Q4 | $364M | Hold |
4,220,048
| – | – | 16.23% | 1 |
|
2020
Q3 | $159M | Buy |
+4,220,048
| New | +$159M | 9.2% | 2 |
|